Clinical consequences of Cushing's syndrome

Pituitary

Volumn 15, Issue 3, 2012, Pages 319-329

  Valassi, Elena ^a,b   Crespo, Iris ^a,b   Santos, Alicia ^a,b   Webb, Susan M ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Co morbidities; Cushing's syndrome; Remission

Indexed keywords

ADIPOCYTOKINE; HYDROCORTISONE;

ARTICLE; ATHEROSCLEROSIS; BONE DENSITY; BONE REMODELING; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; COGNITION; CUSHING SYNDROME; DETERIORATION; DYSLIPIDEMIA; FOLLOW UP; HUMAN; HYPERCOAGULABILITY; HYPERCORTISOLISM; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; LIFE EXPECTANCY; LONGEVITY; METABOLIC SYNDROME X; MOOD; MORBIDITY; MORTALITY; NEPHROLITHIASIS; OBESITY; PRIORITY JOURNAL; QUALITY OF LIFE; REMISSION;

BONE DENSITY; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; CUSHING SYNDROME; FEMALE; HUMANS; QUALITY OF LIFE; RISK;

EID: 84867399867     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-012-0394-8     Document Type: Article

References (73)

1. Pivonello R, Faggiano A, Lombardi G, Colao A (2005) The metabolic syndrome and cardiovascular risk in Cushing's syndrome. Endocrinol Metab Clin N Am 34:327-339
2. Colao AM, Pivonello R, Spiezia R, Faggiano A, Ferone D, Filippella M, Marzullo P, Carbone G, Siciliani M, Lombardi G (1999) Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 84:2664-2672
3. Kemink SAG, Frijns JTM, Hermus ARMM, Pieters GFFM, Smals AGH, van Marken Lichtenbelt WD (1999) Body composition determined by six different methods in women bilaterally adrenalectomized for treatment of Cushing's disease. J Clin Endocrinol Metab 84:3991-3999
4. Leong GM, Abad V, Charmandari E, Reynolds JC, Hill S, Chrousos GP, Nieman LK (2007) Effects of child-and adolescentonset endogenous Cushing syndrome on bone mass, body composition, and growth: a 7-year prospective study into adulthood. J Bone Miner Res 22:110-118
5. Valassi E, Biller MK, Klibanski A, Misra M (2011) Adipokines and cardiovascular risk in Cushing's syndrome. Neuroendocrinology (Epub ahead of print)
6. Barahona MJ, Sucunza N, Resmini E, Fernandes-Real JM, Ricart W, Moreno-Navarrete JM, Puig T, Farrerons J, Webb SM (2009) Persistent body fat mass and inflammatory marker increase after long-term cure of Cushing's syndrome. J Clin Endocrinol Metab 94:3365-3371
7. Masuzaki H, Ogawa Y, Hosoda K, Miyawaki T, Hanakoa I, Yasuno A, Nishimura H, Yoshimasa Y, Nishi S, Nakao K (1997) Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing's syndrome. J Clin Endocrinol Metab 82:2542-2547
8. Kresk M, Silha JV, Jezkova J, Hana V, Marek J, Weiss V, Stepan JJ, Murphy LJ (2004) Adipokine levels in Cushing's syndrome; elevated resistin levels in female patients with Cushing's syndrome. Clin Endocrinol 60:350-357
9. Pecori Giraldi F, Andrioli M, De Marinis L, Bianchi A, Giampietro A, De Martin M, Sacco E, Scacchi M, Pontecorvi F, Cavagnini F (2007) Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease. Eur J Endocrinol 156:233-239
10. Johannsson G, Sunnerhagen KS, Svensson J (2004) Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease. Clin Endocrinol 60:550-559
11. Burt MG, Gibney J, Ho KKY (2006) Characterization of the metabolic phenotypes of Cushing's syndrome and growth hormone deficiency: a study of body composition and energy metabolism. Clin Endocrinol 64:436-443
12. Webb SM, Mo D, Lamberts SWJ, Melmed S, Cavagnini F, Giraldi FP, Strasburger CJ, Zimmermann AG, Woodmansee WW, on behalf of the International HypoCCS Advisory Board (2010) Metabolic, cardiovascular and cerebrovascular outcomes in GH-deficient 1 subjects with previous 2 Cushing's disease or non-functioning pituitary adenoma: a Hypopituitary Control and Complications Study (HypoCCS) analysis. J Clin Endocrinol Metab 95:630-638. doi:10.1210/jc.2009-0806
13. Faggiano A, Pivonello R, Spiezia S, De Martino MC, Filippella M, Di Somma C, Lombardi G, Colao A (2003) Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 88:2527-2533
14. Giraldi FP, Toja PM, De Martin M, Maronati A, Scacchi M, Omboni S, Cavagnini F (2007) Circadian blood pressure profile in patients with active Cushing's disease and after long-term cure. Horm Metab Res 39:908-914
15. Simon D, Goretzki PE, Lollert A, Roher HD (1993) Persistent hypertension after successful adrenal operation. Surgery 114:1189-1195
16. Suzuki T, Shibata H, Ando T, Kurihara I, Kobayashi S, Hayashi M, Kawabe H, Saito I, Murai M, Saruta T (2000) Risk factots associated with persistent postoperative hypertension in Cushing's syndrome. Endocr Res 26:791-795
17. Lodish MB, Sinaii N, Patronas N, Batista DL, Keil M, Samuel J, Moran J, Verma S, Popovic J, Stratakis CA (2009) Blood pressure in pediatric patients with Cushing's síndrome. J Clin Endocrinol Metab 94:2002-2008
18. Toja PM, Branzi G, Ciambellotti F, Radaelli P, De Martin M, Lonati LM, Scacchi M, Parati G, Cavagnini F, Giraldi FP (2011) Clinical relevance of cardiac structure and function abnormalities in patients with Cushing's syndrome before and after cure. Clin Endocrinol 76:332-338
19. Muiesan ML, Lupia M, Salvetti M, Grigoletto C, Sonino N, Boscaro M, Rosei EA, Fallo F (2003) Left ventricular structural and functional characteristics in Cushing's syndrome. J Am Coll Cardiol 41:2275-2279
20. Pereira AM, Delgado V, Romijn JA, Smit JWA, Bax JJ, Feelders RA (2010) Cardiac dysfunction is reversed upon successful treatment of Cushing's disease. Eur J Endocrinol 162:331-340
21. Bassareo PP, Marras AR, Pasqualucci D, Mercuro G (2010) Increased arterial rigidity in children affected by Cushing's Pituitary (2012) 15:319-329
22. Syndrome after successful surgical cure. Cardiol Young 20:610-614
23. Manetti L, Bogazzi F, Giovannetti C, Raffaelli V, Genovesi M, Pellegrini G, Ruocco L, Iannelli A, Martino E (2010) Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery. Eur J Endocrinol 163:783-791
24. Fatti LM, Bottasso B, Invitti C, Coppola R, Cavagnini F, Mannucci PM (2000) Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome. J Endocrinol Invest 23:145-150
25. Van Zaane B, Nur E, Squizzato A, Dekkers OM, Twickler MT, Fliers E, Gerdes VE, Büller HR, Brandjes DP (2009) Hypercoagulable state in Cushing's syndrome: a systematic review. J Clin Endocrinol Metab 94(8):2743-2750
26. Stuijver DJF, van Zaane B, Feelders RA, Debeij J, Cannegieter SC, Hermus AR, van Den Berg G, Pererira AM, de Herder WW, Wagenmakers MAEM, Kerstens MN, Zelissen PMJ, Fliers E, Schaper N, Drent ML, Dekkers OM, Gerders VEA (2011) Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study. J Clin Endocrinol Metab 96:3525-3532
27. Valassi E, Santos A, Yaneva M, Toth M, Strasburger CJ, Chanson P, Wass JAH, Chabre O, Pfeifer M, Feelders RA, Tsagarakis S, Trainer PJ, Franz H, Zopf K, Zacharieva S, Lamberts SWJ, Tabarin A, Webb S (2011) The European Registry on Cushing's syndrome (ERCUSYN): two-year experience. Baseline demographic and clinical characteristics. Eur J Endocrinol 165:383-392
28. Mancini T, Doga M, Mazziotti G, Giustina A (2004) Cushing's syndrome and bone. Pituitary 7:243-246
29. Canalis E, Giustina A (2001) Glucocorticoid-induced osteoporosis: summary of a workshop. J Clin Endocrinol Metab 86: 5681-5685
30. Kristo C, Jemtland R, Ueland T, Godang K, Bollerslev J (2006) Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: a prospective, long-term study. Eur J Endocrinol 154:109-118
31. Manning PJ, Evans MC, Reid IR (1992) Normal bone density following cure of Cushing's syndrome. Clin Endocrinol 36: 229-234
32. Hermus AR, Smals AG, Swinkels LM, Huysmans DA, Pieters GF, Sweep CF, Corstens FH, Kloppenborg PW (1995) Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome. J Clin Endocrinol Metab 80:2859-2865
33. Di Somma C, Pivonello R, Loche R, Faggiano A, Klain M, Salvatore M, Lombardi G, Colao A (2003) Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study. Clin Endocrinol 58:302-308
34. Faggiano A, Pivonello R, Filippella M, Di Somma C, Orio F, Lombardi G, Colao A (2001) Spine abnormalities and damage in patients cured from Cushing's disease. Pituitary 4:153-161
35. Barahona MJ, Sucunza N, Resmini E, Fernandez-Real M, Ricart W, Moreno-Navarrete JM, Puig T, Wagner AM, Rodriguez-Espinosa J, Farrerons J, Webb SM (2009) Deleterious effects of glucocorticoid replacement on bone in women after long-term remission of Cushing's syndrome. J Bone Min Res 24:1841-1846
36. Vestergaard P, Lindholm J, Jorgensen JO, Hagen C, Hoek HC, Laurberg P, Rejnmark L, Brixen K, Kristensen LO, Feldt-Rasmussen U, Mosekilde L (2002) Increased risk of osteoporotic fractures in patients with Cushing's syndrome. Eur J Endocrinol 146:51-56
37. Faggiano A, Pivonello R, Melis D, Filippella M, Di Somma C, Petretta M, Lombardi G, Colao A (2003) Nephrolithiasis in Cushing's disease: prevalence, etiopathogenesis, and modification after disease cure. J Clin Endocrinol Metab 88:2076-2080
38. Faggiano A, Pivonello R, Melid D, Alfieri R, Filippella M, Spagnuolo G, Salvatore F, Lombardi G, Colao A (2002) Evaluation of circulating levels and renal clearance of natural aminoacids in patients with Cushing's disease. J Endocrinol Invest 25:142-151
39. Maalouf NM (2011) Metabolic syndrome and the genesis of uric acid stones. J Ren Nutr 21:128-131
40. Forget H, Lacroix A, Somma M, Cohen H (2000) Cognitive decline in patients with Cushing's syndrome. J Int Neuropsychol Soc 6:20-29
41. Starkman MN, Gebarski SS, Berent S, Schteingart DE (1992) Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry 32:756-765
42. Michaud K, Forget H, Cohen H (2009) Chronic glucocorticoid hypersecretion in Cushing's syndrome exacerbates cognitive aging. Brain Cogn 71:1-8
43. León-Carrión J, Atutxa AM, Mangas MA, Soto-Moreno A, Pumar A, León Justel A, Martín Rodríguez JF, Venegas E, Dominguez- Morales MR, Leal-Cerro A (2009) A clinical profile of memory impairment in humans due to endogenous glucocorticoid excess. Clin Endocrinol (Oxf) 70:1-8
44. Sonino N, Fava GA, Raffi AR, Boscaro M, Fallo F (1998) Clinical correlates of major depression in Cushing's disease. Psychopathology 31:302-306
45. Starkman MN, Giordani B, Berent S, Shork MA, Schteingart DE (2001) Elevated cortisol levels in Cushing's disease are associated with cognitive decrement. Psychosom Med 63:985-993
46. Starkman MN, Giordani B, Gebarski SS (2007) Improvement in mood and ideation associated with increase in right caudate volume. J Affect Disord 101:139-147
47. Bourdeau I, Bard C, Noël B, Leclerc I, Cordeau MP, Bélair M, Lesage J, Lafontaine L, Lacroix A (2002) Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab 87: 1949-1954
48. Mauri M, Sinforiani E, Bono G, Vignati F, Berselli ME, Attanasio R, Nappi G (1993) Memory impairment in Cushing's disease. Acta Neurol Scand 87:52-55
49. Dorn LD, Burgess ES, Friedman TC, Dubbert B, Gold PW, Chrousos GP (1997) The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 82:912-919
50. Hook JN, Giordani B, Schteingart DE, Guire K, Giles J, Ryan K, Gebarski SS, Langenecker SA, Starkman MN (2007) Patterns of cognitive change over time and relationship to age following successful treatment of Cushing's disease. J Int Neuropsychol Soc 13:21-29
51. Merke DP, Giedd JN, Keil MF, Mehlinger SL, Wiggs EA, Holzer S, Rawson E, Vaituzis AC, Stratakis CA, Chrousos GP (2005) Children experience cognitive decline despite reversal of brain atrophy one year after resolution of Cushing's syndrome. J Clin Endocrinol Metab 90:2531-2536
52. Tiemensma J, Kokshoorn NE, Biermasz NR, Keijser BSA, Wassenaar MJE, Middelkoop HAM, Pereira AM, Romijn JA (2010) Subtle cognitive impairment in patients with long-term cure of Cushing's disease. J Clin Endocrinol Metab 95:1-16
53. Resmini E, Santos A, Gómez-Anson B, Vives Y, Pires P, Crespo I, Portella MJ, Delago MJ, Barahona MJ, Webb SM (2012) Verbal and visual memory performance and hippocampal volumes, measured by 3-tesla magnetic resonance imaging, in patients with Cushing's syndrome. J Clin Endocrinol Metab 97:663-671
54. Tiemensma J, Biermasz NR, Middlekoop HAM, van der Mast RC, Romijn JA, Pereira AM (2010) Increased prevalence of psychopathology and maladaptive personality traits after longterm cure of Cushing's disease. J Clin Endocrinol Metab 95:E129-E141
55. Sonino N, Fava GA (1998) Psychological aspects of endocrine disease. Clin Endocrinol (Oxf) 49:1-7
56. Johnson MD, Woodburn CJ, Vance ML (2003) Quality of life in patients with a pituitary adenoma. Pituitary 6:81-87
57. Van Aken MO, Pereira AM, Biermasz NR, van Thiel SW, Hoftijzer HC, Smit JW, Roelfsema F, Lamberts SW, Romijn JA (2005) Quality of life in patients after long-term biochemical cure of Cushing's disease. J Clin Endocrinol Metab 90(6):3279-3286
58. Lindholm J, Juul S, Jorgensen JO, Astrup J, Bjerre P, Feldt- Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K, Weeke J (2001) Incidence and late prognosis of Cushing's syndrome: a population-based study. J Clin Endocrinol Metab 86:117-123
59. Lindsay JR, Nansel T, Baid S, Gumowski J, Nieman LK (2006) Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab 91(447):453
60. Hawn MT, Cook D, Deveney C, Sheppard BC (2002) Quality of life after laparoscopic bilateral adrenalectomy for Cushing's disease. Surgery 132:1064-1068
61. Nagesser SK, van Seters AP, Kievit J, Hermans J, Krans HM, van de Velde CJ (2000) Long-term results of total adrenalectomy for Cushing's disease. World J Surg 24:108-113
62. Pikkarainen L, Sane T, Reunanen A (1999) The survival and well-being of patients treated for Cushing's syndrome. J Intern Med 245:463-468
63. Webb SM, Badia X, Barahona MJ, Colao A, Strasburger CJ, Tabarin A, van Aken MO, Pivonello R, Stalla G, Lamberts SWJ, Glusman JE (2008) Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire. Eur J Endocrinol 158:623-630
64. Malik IA, Foy P, Wallymahmed M, Wilding JP, MacFarlane IA (2003) Assessment of quality of life in adults receiving long-term growth hormone replacement compared to control subjects. Clin Endocrinol (Oxf) 59:75-81
65. Feldt-Rasmussen U, Abs R, Bengstsson BA, Bennmarker H, Bramnert M, Hernberg-Stahl E, Monson JP, Westberg B, Wilton P, Wuster C (2002) Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease. Eur J Endocrinol 146:67-74
66. Thompson SK, Hayman AV, Ludlam WH, Deveney CW, Loriaux DL, Sheppard BC (2007) Improved quality of life after bilateral adrenalectomy for Cushing's disease: a 10-year experience. Ann Surg 245:790-794
67. Smith PW, Turza KC, Carte CO (2009) Bilateral adrenalectomy for refractory Cushing's disease: a safe and definitive therapy. J Am Coll Surg 208:1059-1064
68. Plotz D, Knowlton AI, Ragan C (1952) The natural history of Cushing's disease. Am J Med 13:597-614
69. Clayton RN, Raskauskiene D, Reulen RC, Jones PW (2011) Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. J Clin Endocrinol Metab 96(3):1-11
70. Extabe J, Vazquez JA (1994) Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol 4:479-484
71. Dekkers OM, Biermasz NR, Pereira AM, Roelfsema F, van Aken MO, Voormolen KHC, Romijn JA (2007) Mortality in patients treated for Cushing's disease is increased, compared with patients treated for non-functioning pituitary macroadenomas. J Clin Endocrinol Metab 92:976-981
72. Hammer GD, Tyrrel JB, Lamborn KR, Apllebury CD, Hannegan ET, Bell S, Rahal R, Lu A, Wilson CB (2004) Transsphenoidal microsurgery for Cushing's disease: initial outcomes and longterm results. J Clin Endocrinol Metab 89:6348-6357
73. Swearingen B, Biller BM, Barker FG 2nd, Katznelson L, Grinspoon S, Klibanski A, Zervas N (1999) Long-term mortality after transsphenoidal surgery for Cushing's disease. Ann Intern Med 130:821-824